Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

Assessment of Effectiveness and Impact of Universal Prophylaxis With Nirsevimab for Prevention of Hospitalizations Due to Respiratory Syncytial Virus in Infants. The NIRSE-GAL Study Protocol
2024 · Instituto de Investigación Sanitaria, · World Health Organization (WHO), · University of Santiago de Compostela, · Instituto de Salud Carlos III
The NIRSE-GAL study in Galicia, Spain, aims to assess the effectiveness of nirsevimab in preventing hospitalizations due to Respiratory Syncytial Virus (RSV) in infants. It …
Evaluation of Antibody-Based Preventive Alternatives for Respiratory Syncytial Virus: A Novel Multi-Criteria Decision Analysis Framework and Assessment of Nirsevimab in Spain
2024 · University Carlos III, · BioMad, · Fisabio-Public Health, · Catholic University of Valencia, · Instituto de Salud Carlos III, · Weber Foundation
This study evaluates nirsevimab, an antibody-based preventive measure for respiratory syncytial virus (RSV) in Spain. Using a multi-criteria decision analysis framework, experts found that nirsevimab …
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
2024 · Fisabio-Public Health, · Instituto de Salud Carlos III, · University of Valencia
This study in Spain evaluated nirsevimab's efficacy in preventing respiratory syncytial virus (RSV) infections in infants under ten months. The immunization campaign targeted all infants …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie